Clinical trial

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

NCT00841113

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Abarelix Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Goserelin plus Bicalutamide Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-01-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

AbarelixDRUG

Goserelin plus BicalutamideDRUG

Sponsors & collaborators

Speciality European Pharma Limitedlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00841113 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.